{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of CEA-Specific Fluorescence Imaging in Cytoreductive Surgery for Colorectal Cancer"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Fourteen patients diagnosed with peritoneal metastases of colorectal origin were included."
      },
      "Intervention": {
        "score": 2,
        "evidence": "SGM-101 was administered intravenously 4\u20136 days before surgery."
      },
      "Objective": {
        "score": 1,
        "evidence": "This multicentre pilot study aimed to assess the role of carcinoembryonic antigen (CEA)-specific fluorescence imaging using SGM-101 during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) in patients with peritoneal metastasized colorectal cancer."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in the peritoneal carcinomatosis index (PCI) due to fluorescence imaging, measured intraoperatively."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and blinding details were not applicable as this was a pilot study."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation and blinding details were not applicable as this was a pilot study."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Fourteen patients diagnosed with peritoneal metastases of colorectal origin were included."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "A correct change in PCI due to fluorescence imaging was observed in 4 of the 14 patients."
      },
      "Harms": {
        "score": 1,
        "evidence": "SGM-101 was well tolerated, with no allergic or anaphylactic reactions reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "No trial registration or funding details were provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "No trial registration or funding details were provided."
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}